The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Galliker Stephen S since year 2005.
The trader's CIK number is 1249422.
At the time of the last reporting, Galliker Stephen S was the Director of Sellas Life Sciences Group, Inc. .
(stock ticker symbol SLS).
See this page for all insider trading activities at Sellas Life Sciences Group, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-02-03||GALE||Sellas Life Sciences Group, Inc.||Sale||300,000||4.18||1,253,099|
|2014-02-03||GALE||Sellas Life Sciences Group, Inc.||Option Ex||300,000||1.35||406,200|
|2010-06-18||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
|2010-03-26||RXII||Sellas Life Sciences Group, Inc.||Sale||15,000||5.54||83,100|
|2009-06-19||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
|2008-06-21||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
|2007-06-21||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Galliker Stephen S (Director of Sellas Life Sciences Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.